scispace - formally typeset
P

Patrick G. Shaw

Researcher at Johns Hopkins University

Publications -  13
Citations -  3709

Patrick G. Shaw is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Proteomics & Stable isotope labeling by amino acids in cell culture. The author has an hindex of 13, co-authored 13 publications receiving 3254 citations. Previous affiliations of Patrick G. Shaw include Johns Hopkins University School of Medicine & University of Pittsburgh.

Papers
More filters
Journal ArticleDOI

A draft map of the human proteome

Min-Sik Kim, +73 more
- 29 May 2014 - 
TL;DR: A draft map of the human proteome is presented using high-resolution Fourier-transform mass spectrometry to discover a number of novel protein-coding regions, which includes translated pseudogenes, non-c coding RNAs and upstream open reading frames.
Journal ArticleDOI

C9orf72 nucleotide repeat structures initiate molecular cascades of disease

TL;DR: It is demonstrated that distinct C9orf72 HRE structural polymorphism at both DNA and RNA levels initiates molecular cascades leading to ALS/FTD pathologies, and provides the basis for a mechanistic model for repeat-associated neurodegenerative diseases.
Journal ArticleDOI

Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles

TL;DR: Significant changes in transcriptomic and proteomic changes in the estrogen receptor negative, non-tumorigenic human breast epithelial MCF10A cell line were analyzed to identify potential biomarkers that can be used in clinical trials to investigate the initial pharmacodynamic action of SFN in the breast.
Journal ArticleDOI

Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells

TL;DR: This study suggests that LSD1 intimately interacts with histone deacetylases in human breast cancer cells, and may represent a promising and novel approach for epigenetic therapy of breast cancer.